• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

The United States Market for In Vitro Diagnostic Tests: Forecasts to 2018

$1,995.00 – $3,990.00

Clear
SKU: KLI5217921 Categories: Clinical Chemistry, Diagnostics Market Research, Oncology & Hematology Market Reports, Point-of-Care Diagnostics Pages: 130
  • Description
  • Table of Contents
  • Latest reports

Description

The United States is the world’s largest in vitro diagnostics and nearly half of the global IVD market. While companies seek emerging markets for growth, most healthcare business is generated in the United States and its volume is still a strong advantage of this market.  Most recently the U.S. IVD market weathered interrupted lab and healthcare sector investment in anticipation of the Affordable Care Act and several regulatory and austerity measures on the part of government payers that constricted payments for clinical testing.

In this report, The United States Market for In Vitro Diagnostic Tests, Kalorama Information analyst Emil Salazar takes a considered look into these trends and what they mean for diagnostic manufacturers and investors.

As the report notes, there are both challenging developments and postiive trends which make the United States a stable IVD market: The expansion of the insured population under the ACA; demographic aging that increases demand for clinical testing and a medical program that serves as a leading, stable vehicle for payment (Medicare); relatively optimistic macroeconomic indicators vis-à-vis the domestic outlook five years ago or other developed markets in the world; and continued product innovation and industry responsiveness to clients’ needs in the world’s largest IVD market.

This report includes important tools for business planners, including market size estimates and forecasts for the following IVD segments:

  • Point of Care  (Glucose, Professional, OTC)
  • Histology and Cytology
  • Clinical Chemistry
  • Immunoassays (Infectious Disease, Non-Infectious Disease)
  • Molecular Assays (Non-Infectious Disease)
  • Hematology
  • Urinalysis
  • Flow Cytometry
  • Coagulation
  • Microbiology and Virology (ID/AST, Molecular)
  • Blood Testing

Market sizes, forecasts and shares are provided, as well as a geographic breakdown of the segments, where possible. Changes in technology development, regulatory and reimbursement issues, clinical care, and business environments are discussed. Current market numbers are presented for 2011, with projections given through 2016. The following data points are included in this report:

  • U.S. Health Expenditure
  • U.S. Clinical Lab Expenditure
  • U.S. Infectious Disease Market Opportunities
  • Affordable Care Act (ACA)
  • Clinical Testing under Medicare – Reimbursement Cuts and “Revaluation”
  • Molecular Diagnostics and Medicare Policy
  • Patient Population
  • Healthcare System Utilization
  • Aging
  • Disease Prevalence and Incidence
  • Analyst Conclusions About the Market

Many of the top IVD companies use Kalorama Information products for business planning, which means that this volume can provide a uniform standard for in vitro diagnostic market numbers. This edition greatly expands coverage of the field and tracks the most important developments. See aspects of the industry that might not be available in your company’s internal resources. View the market from an independent point of view. Learn about competitors in away that may be invisible to internal personnel. Know the market players – your competitors and potential partners, in proper context and classification. Save countless hours of staff time and other research expenses with the authoritative guide for IVD market estimates and forecasts.

As part of the reports, the following companies are covered:

  • Abbott Diagnostics
  • Alere
  • Beckman Coulter
  • Becton Dickinson
  • Danaher Corporation
  • Hologic
  • Ortho-Clinical Diagnostics / J&J Diabetes Care
  • QIAGEN
  • Roche Diagnostics
  • Siemens Healthcare Diagnostics
  • Sysmex Corporation
  • Thermo Fisher Scientific

Table of Contents

CHAPTER ONE: EXECUTIVE SUMMARY

Introduction

Market Metrics – System Utilization

U.S. Hospital Inpatient Admissions and Outpatient Visits Per 1,000 Persons (1991-2011)

Market Metrics – Aging

Historical and Projected U.S. Aged Populations (% Share of Total Population, Population in Millions) (1950-2050)

Market Metrics – Disease

U.S. Infectious Disease Market Opportunities Ranked

Market Metrics – U.S. Total Health and Clinical Lab Expenditures and Payers

Market Metrics – U.S. Clinical Testing by Channel

Impacts of the Affordable Care Act

Impacts of CLFS Cuts and Molecular Reimbursement Reform

U.S. IVD Market

U.S. IVD Market by Segment

Top Tier U.S. IVD Market Participants and Rankings

U.S. IVD Market Rankings by Estimated 2013 Revenue – Top 12 Companies

Conclusions

CHAPTER TWO: INTRODUCTION TO U.S. HEALTH CARE

The United States and In Vitro Diagnostics

U.S. Patient Population

Healthcare System Utilization

Aging

Disease Prevalence and Incidence

Health Insurance in the United States and the Affordable Care Act (ACA)

U.S. Health Expenditure

U.S. Clinical Lab Expenditure

Affordable Care Act (ACA)

Clinical Testing under Medicare – Reimbursement Cuts and “Revaluation”

Molecular Diagnostics and Medicare Policy

U.S. Healthcare Infrastructure and Testing Channels

Hospitals

Independent Labs

Physician Office Laboratories (POLs)

Self-Testing

Retail Clinics

Other Labs

Conclusions

CHAPTER THREE: U.S. IVD MARKET ANALYSIS

Clinical Chemistry

Microbiology and Virology, ID/AST and Molecular

Point of Care Testing

Immunoassays

Urinalysis

Molecular Diagnostics

Coagulation

Histology

Hematology

Blood Testing and Typing

Flow Cytometry

Total U.S. IVD Market

CHAPTER FOUR: TOP TIER U.S. IVD MARKET PLAYERS

Abbott Diagnostics

Core Lab

Molecular

Diabetes

Alere

Critical Care

Infectious Disease

Consumer Diagnostics

Beckman Coulter

Clinical Chemistry

Immunoassays

Hematology

Flow Cytometry

Becton Dickinson

Molecular

Rapid Tests

Flow Cytometry

Danaher Corporation

Histology

Point-of-Care Testing

Hologic

Molecular Diagnostics / Histology

Ortho-Clinical Diagnostics / J&J Diabetes Care

Blood Banking

QIAGEN

Companion Diagnostics / Cancer Markers

Infectious Disease

Immunoassays

Roche Diagnostics

Professional Diagnostics

Diabetes Care

Molecular Diagnostics

Siemens Healthcare Diagnostics

Clinical Chemistry/Immunoassays

Immunoassays

Microbiology

Companion Diagnostics

Urinalysis

Coagulation

Point-of-Care Diagnostics

Sysmex Corporation

Hematology

Coagulation

Thermo Fisher Scientific

Immunoassays

Microbiology

Molecular Diagnostics

LIST OF EXHIBITS

CHAPTER ONE: EXECUTIVE SUMMARY

Table 1-1: U.S. Hospital Inpatient Admissions and Outpatient Visits Per 1,000 Persons

(1991-2011)

Table 1-2: Historical and Projected U.S. Aged Populations, % Share of Total Population,

Population in Millions (1950-2050)

Table 1-3: U.S. Infectious Disease Market Opportunities Ranked

Table 1-4: U.S. IVD Market by Segment

Table 1-5: U.S. IVD Market Rankings by Estimated 2013 Revenue – Top 12 Companies

CHAPTER TWO: INTRODUCTION TO U.S. HEALTH CARE

Figure 2-1: US IVD Market, 2013 and 2018

Table 2-1: U.S. Hospital Inpatient Admissions and Outpatient Visits Per 1,000 Persons (1991-2011)

Table 2-2: Historical and Projected U.S. Aged Populations(1950-2050)

Table 2-3: U.S. Adult Diabetes Prevalence – Age-Adjusted and Crude Rates(2002-2012)

Table 2-4: U.S. Cancer Incidence – Aggregate, Lung, Colon, Prostate, Breast(per 100,000 persons) (2000-2010)

Table 2-5: Selected Notifiable Infectious Disease Incidences in the United States(per 100,000 persons) (2001-2011)

Table 2-6: U.S. Infectious Disease Market Opportunities Ranked

Table 2-7: U.S. National Health Expenditure by Payer (Out-of-Pocket, Private Health

Insurance, Medicare, Medicaid) (2002-2022)

Table 2-8: U.S. Clinical Laboratory Market by Segment – Hospital, Independent,

Physician Office ($ millions) (2008-2018)

CHAPTER THREE: U.S. IVD MARKET ANALYSIS

Figure 3-1: US Clinical Chemistry Market

Figure 3-2: US Microbiology and Virology, ID/AST and Molecular Market

Figure 3-3: US Point of Care Testing Market

Figure 3-4: US Immunoassays Market

Figure 3-5: US Urinalysis Market

Figure 3-6: US Molecular Diagnostics Market

Figure 3-7: US Coagulation Market

Figure 3-8 US Histology Market

Figure 3-9 US Hematology Market

Figure 3-10 US Blood Testing and Typing Market

Figure 3-11: US Flow Cytometry Market

Table 3-1: U.S. IVD Market by Segment

CHAPTER FOUR: TOP TIER U.S. IVD MARKET PLAYERS

Table 4-1: Abbott Diagnostics Estimated Global Revenue by IVD Segment – (Core Lab,

Hematology, POC, Molecular, Diabetes) (2011-2013)

Table 4-2: Alere Global Revenue by IVD Segment – (Professional POC, Infectious Disease,

Toxicology, Diabetes, Other; Consumer [OTC] Diagnostics) (2011-2013)

Table 4-3: Beckman Coulter Global Estimated Revenue by IVD Segment – (Clinical Chemistry,

Immunoassays, Hematolgy, Flow Cytometry) (2011-2013)

Table 4-4: Becton Dickinson Global Estimated Revenue by IVD Segment – (Histology, Molecular,

Microbiology [ID/AST, Media, Rapid Tests, Blood Culture], Flow Cytometry)(2011-2013)

Table 4-5: Danaher Corporation Global Estimated Revenue by Subsidiary Group – (Beckman Coulter,

Radiometer, Leica Biosystems, Leica Microsystems, AB Sciex, Molecular Diagnostics)(FY 2011-2013)

Table 4-6 Hologic Estimated Global Revenue by Product Group – (HPV, ThinPrep, Gen-Probe

Clinical Molecular, Gen-Probe Blood Banking) (FY 2011-2013)

Table 4-7: Ortho-Clinical Diagnostics / J&J Diabetes Care Estimated Global Revenue by Product

Group – (OTC Diabetes [SMBG], Immunoassays, Chemistry, Blood Banking)(2011-2013)

Table 4-8: QIAGEN Estimated Global Revenue by Segment – (HPV, Other Molecular Clinical

Applied Testing, Pharma, Academia) (2011-2013)

Table 4-9: Roche Diagnostics Estimated Global Revenue by Segment – (Professional Diagnostics,

Diabetes Care, Molecular Diagnostics, Tissue Diagnostics) (2011-2013)

Table 4-10 Siemens Healthcare Diagnostics Estimated Global Revenue by Segment – (Hematology,

Coagulation, Chemistry/Immunoassays, Microbiology, Urinalysis, Blood Gases)(2011-2013)

Table 4-11: Sysmex Corporation Estimated Global Revenue by Segment – (Hematology, Coagulation,

Urinalysis, Chemistry/Immuno, Other IVD) (2011-2013)

Table 4-12 Thermo Fisher Scientific Estimated Global Revenue by Segment – (Clinical Products,

Immunoassays [Phadia], Microbiology, Histology, Transplant Diagnostics)(2011-2013)

 

    In Vitro Diagnostics Business Outlook, 2025 (6 Issues)
    April 3, 2025
    The World Market for HbA1c Testing: Trends, Technologies, and Growth Opportunities, 2025
    February 14, 2025
    In Vitro Diagnostics Business Outlook, 2024 (6 updates)
    December 20, 2024
    The Worldwide Market for Clinical Laboratory Services, 9th Edition
    June 26, 2024

Related products

  • Placeholder image

    Medical Imaging Markets, Volume III – Ultrasound

    $1,200.00 – $5,990.00
  • Placeholder image

    U.S. Market for Over-the-Counter Diagnostics: Product Sales and Consumer Survey, The

    $4,995.00 – $9,990.00
  • Placeholder image

    In Vitro Diagnostic Tests and Systems: The World Outside the United States

    $596.00 – $1,192.00
  • Placeholder image

    Molecular Diagnostics for Pharmacogenetic Testing: Testing volume, cost per test, and market potential

    $995.00 – $1,990.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025
  • IVD Trends to Watch: Personalized Medicine Adds Precision to Diagnostic Testing January 2, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
Retail Clinics Market Overview and 2014 Survey ResultsEMR 2014: The Market for Electronic Medical Records
Scroll to top